MedTrace Logo

Trial of Antimicrobial Restraint in Presumed Pneumonia

NCT04438187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 186

Last updated 2024-08-19

No results posted yet for this study

Summary

The objective of this cluster-randomized crossover study is to determine the effect of delaying antimicrobial initiation until objective microbiologic data is obtained in patients with presumed ICU-acquired pneumonia without septic shock.

Conditions

  • Healthcare-Associated Pneumonia
  • Sepsis

Interventions

OTHER

antimicrobial initiation

antimicrobial initiation based on protocol assignment.

Sponsors & Collaborators

  • Western Michigan University

    collaborator OTHER

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Christopher Guidry · KU Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-01-06
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04438187 on ClinicalTrials.gov